PRABHAKER PATEL: Open Payments
NPI 1639242852 · TURNERSVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,863 in 181 payments from 21 companies in 2025. Trend: 2023 $2,466 · 2024 $3,056 · 2025 $2,863
Food & beverage: $2,863
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 26 | $435 |
| Neurocrine BioSciences, Inc. | 25 | $403 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $322 |
| ABBVIE INC. | 15 | $196 |
| Alkermes, Inc. | 9 | $177 |
| E.R. Squibb & Sons, L.L.C. | 11 | $151 |
| Axsome Therapeutics, Inc. | 11 | $149 |
| Teva Pharmaceuticals USA, Inc. | 11 | $145 |
| Tris Pharma Inc | 12 | $142 |
| Lundbeck LLC | 7 | $114 |
Products named: FANAPT, INGREZZA, CAPLYTA, VRAYLAR, REXULTI, LYBALVI, COBENFY, Auvelity.
Industry payments across NJ — which companies pay providers there.
